Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy.
Neonatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna St. Orsola Polyclinic, Via Massarenti 9, 40138, Bologna, BO, Italy.
BMC Med Genomics. 2022 Dec 21;15(1):266. doi: 10.1186/s12920-022-01422-6.
Down syndrome (DS) is caused by the presence of an extra copy of full or partial human chromosome 21 (Hsa21). Partial (segmental) trisomy 21 (PT21) is the duplication of only a delimited region of Hsa21 and can be associated or not to DS: the study of PT21 cases is an invaluable model for addressing genotype-phenotype correlation in DS. Previous works reported systematic reanalyses of 132 subjects with PT21 and allowed the identification of a 34-kb highly restricted DS critical region (HR-DSCR) as the minimal region whose duplication is shared by all PT21 subjects diagnosed with DS.
We report clinical data and cytogenetic analysis of two children with PT21, one with DS and the other without DS. Moreover, we performed a systematic bibliographic search for any new PT21 report.
Clinical and cytogenetic analyses of the two PT21 children have been reported: in Case 1 the duplication involves the whole long arm of Hsa21, except for the last 2.7 Mb, which are deleted as a consequence of an isodicentric 21: the HR-DSCR is within the duplicated regions and the child is diagnosed with DS. In Case 2 the duplication involves 7.1 Mb of distal 21q22, with a deletion of 2.1 Mb of proximal 20p, as a consequence of an unbalanced translocation: the HR-DSCR is not duplicated and the child presents with psychomotor development delay but no clinical signs of DS. Furthermore, two PT21 reports recently published (named Case 3 and 4) have been discussed: Case 3 has DS diagnosis, nearly full trisomy for Hsa21 and a monosomy for the 21q22.3 region. Case 4 is a baby without DS and a 0.56-Mb duplication of 21q22.3. Genotype-phenotype correlation confirmed the presence of three copies of the HR-DSCR in all DS subjects and two copies in all non-DS individuals.
The results presented here are fully consistent with the hypothesis that the HR-DSCR is critically associated with DS diagnosis. No exception to this pathogenetic model was found. Further studies are needed to detect genetic determinants likely located in the HR-DSCR and possibly responsible for core DS features, in particular intellectual disability.
唐氏综合征(DS)是由于人类 21 号染色体(Hsa21)的全部或部分额外拷贝引起的。部分(片段)三体 21 (PT21)是 Hsa21 中仅限定区域的重复,并且可以与 DS 相关或不相关:PT21 病例的研究是解决 DS 中基因型-表型相关性的宝贵模型。以前的工作对 132 例 PT21 患者进行了系统的重新分析,确定了一个 34kb 的高度受限的 DS 关键区域(HR-DSCR),作为所有被诊断为 DS 的 PT21 患者共有的最小区域。
我们报告了两名 PT21 患儿的临床数据和细胞遗传学分析,其中一名患儿患有 DS,另一名患儿没有 DS。此外,我们还进行了系统的文献检索,以寻找任何新的 PT21 报告。
报告了两名 PT21 患儿的临床和细胞遗传学分析:在病例 1 中,重复涉及 Hsa21 的整条长臂,除了最后 2.7Mb 因等臂 21 缺失外:HR-DSCR 位于重复区域内,患儿被诊断为 DS。在病例 2 中,重复涉及 21q22 的远端 7.1Mb,近端 20p 缺失 2.1Mb,是由于不平衡易位所致:HR-DSCR 没有重复,患儿表现为精神运动发育迟缓,但没有 DS 的临床症状。此外,还讨论了最近发表的两份 PT21 报告(分别命名为病例 3 和 4):病例 3 有 DS 诊断,Hsa21 几乎全三体,21q22.3 区域单体。病例 4 是一个没有 DS 的婴儿,21q22.3 有 0.56Mb 重复。基因型-表型相关性证实,所有 DS 患者均有 HR-DSCR 的三个拷贝,所有非 DS 个体均有两个拷贝。
这里提出的结果完全符合 HR-DSCR 与 DS 诊断密切相关的假设。没有发现这个发病机制模型的例外。需要进一步研究以检测可能位于 HR-DSCR 中的遗传决定因素,这些遗传决定因素可能导致 DS 的核心特征,特别是智力残疾。